Malta vs North Macedonia: Access to anti-retroviral drugs, female
Malta
47.0%
in 2024
North Macedonia
49.0%
in 2024
Malta rank
124th
North Macedonia rank
123rd
Access to anti-retroviral drugs, female over time
- Malta
- North Macedonia
How they compare
North Macedonia currently reports 49.0% against 47.0% in Malta, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Malta ahead.
Malta ranks 124th and North Macedonia ranks 123rd of 141 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.5% | 21.2% | 3.3% | Malta |
| 2010s | 49.1% | 45.3% | 3.8% | Malta |
| 2020s | 68.4% | 46.2% | 22.2% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Malta or North Macedonia?
- North Macedonia, at 49.0% against 47.0% in Malta as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Malta and North Macedonia?
- 2.0%, with North Macedonia ahead.
- How many years of comparable data are there for Malta and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Malta and North Macedonia rank globally for access to anti-retroviral drugs, female?
- Malta ranks 124th and North Macedonia ranks 123rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.